Literature DB >> 1487384

Psychologic distress during the menopausal years in women attending a menopause clinic.

D E Stewart1, K Boydell, C Derzko, V Marshall.   

Abstract

OBJECTIVE: This study measures psychologic distress in women attending a menopause clinic to determine if significant differences exist between peri-menopausal and menopausal women.
METHOD: Consecutive women attending a university hospital menopause clinic were administered the Brief Symptom Inventory (BSI) and a study questionnaire to determine menopausal symptoms, menstrual cycle status, and use of hormone replacement therapy (HRT). The BSI results were compared between menopausal and perimenopausal women, and to a normative sample of middle-aged women who were nonpatients.
RESULTS: Two hundred and fifty-nine menopause clinic women completed the questionnaire: 113 perimenopausal and 146 menopausal women. There was significantly greater psychologic distress on the BSI among perimenopausal as compared to menopausal women on the global severity index, and each of the anxiety, hostility, somatization, depression, paranoid, and psychoticism subscales. Perimenopausal women met BSI caseness severity criteria significantly more often than did menopausal women on the global severity index, and on the subscales for depression, anxiety, and psychoticism. On the BSI, menopausal women showed results similar to those of a normative sample of nonpatient middle-aged women.
CONCLUSIONS: Perimenopausal women attending menopause clinics have significantly higher levels of psychologic distress meeting case severity criteria on the BSI. Further research is warranted to define the subgroups of perimenopausal women who are at increased risk, in the hopes of developing effective interventions.

Entities:  

Mesh:

Year:  1992        PMID: 1487384     DOI: 10.2190/EWRH-4P7E-ACMH-3MEN

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  5 in total

1.  Does risk for anxiety increase during the menopausal transition? Study of women's health across the nation.

Authors:  Joyce T Bromberger; Howard M Kravitz; Yuefang Chang; John F Randolph; Nancy E Avis; Ellen B Gold; Karen A Matthews
Journal:  Menopause       Date:  2013-05       Impact factor: 2.953

Review 2.  Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics.

Authors:  Marie K Osterlund; Michael-Robin Witt; Jan-Ake Gustafsson
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

Review 3.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 4.  Reproductive aging, sex steroids, and mood disorders.

Authors:  Veronica Harsh; Samantha Meltzer-Brody; David R Rubinow; Peter J Schmidt
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

5.  The role of physical activity in the link between menopausal status and mental well-being.

Authors:  Dmitriy Bondarev; Sarianna Sipilä; Taija Finni; Urho M Kujala; Pauliina Aukee; Eija K Laakkonen; Vuokko Kovanen; Katja Kokko
Journal:  Menopause       Date:  2020-04       Impact factor: 3.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.